Transcrip offers experts to augment in-house drug development

By Gareth Macdonald

- Last updated on GMT

Related tags Drug development Partnership Pharmacology Pharmaceutical industry

Transcrip offers experts to augment in-house drug development
Transcrip Partners’ “augmentation” solution for contract R&D “differs from the normal consultancy alternative by fielding ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty” according to senior partner Paul Branthwaite.

The international partnership consists of almost 20 pharma industry experts and academics who work with clients’ in-house drug development teams on a contractual basis.

As Branthwaite explained Transcrip aims to “provide knowledge and operational capability in drug development in its widest context, working across multiple therapeutic and ‘functional’ areas.”

Already substantial by consulting group standards in the pharma space, it offers a flexible resourcing model that allows clients to access Partners’ capabilities to fill skill, experience and/or resource gaps, by integrating with and augmenting client teams​.”

Related news

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers